信件：经动脉化疗栓塞治疗的肝细胞癌患者的肝功能障碍与生存情况 - Suppr | 超能文献

Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation.

作者信息

Saito M, Seo Y, Yano Y, Miki A, Momose K, Hirano H, Yoshida M, Azuma T

出版信息

Aliment Pharmacol Ther. 2012 Apr;35(7):861-2; author reply 862-3. doi: 10.1111/j.1365-2036.2012.05021.x.

DOI:10.1111/j.1365-2036.2012.05021.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation.信件：经动脉化疗栓塞治疗的肝细胞癌患者的肝功能障碍与生存情况

Aliment Pharmacol Ther. 2012 Apr;35(7):861-2; author reply 862-3. doi: 10.1111/j.1365-2036.2012.05021.x.

2

Commentary: the impact of compact lipiodolisation following transarterial chemoembolisation for hepatocellular carcinoma.述评：经动脉化疗栓塞术后致密碘化油栓塞对肝细胞癌的影响

Aliment Pharmacol Ther. 2012 Jul;36(1):74-5; discussion 75. doi: 10.1111/j.1365-2036.2012.05125.x.

3

Transarterial chemoembolization using doxorubicin beads for unresectable hepatocellular carcinoma.使用阿霉素微球经动脉化疗栓塞治疗不可切除的肝细胞癌。

Onkologie. 2010;33(1-2):5-6. doi: 10.1159/000271594. Epub 2010 Jan 22.

4

Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma.经动脉化疗栓塞术治疗肝细胞癌患者后 SNACOR 临床评分系统的验证。

BMC Cancer. 2018 Apr 27;18(1):489. doi: 10.1186/s12885-018-4407-5.

5

Outcome of inoperable hepatocellular carcinoma patients receiving transarterial chemoembolisation: a real-life retrospective analysis in a Hong Kong regional hospital.接受经动脉化疗栓塞术的不可切除肝细胞癌患者的治疗结果：香港一家地区医院的真实回顾性分析。

Hong Kong Med J. 2009 Oct;15(5):339-45.

6

Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma.肝细胞癌治疗中切除术、肝移植术与经导管油性化疗栓塞术的比较

Wiad Lek. 1997;50 Suppl 1 Pt 1:413-5.

7

Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma.经动脉化疗栓塞术治疗不可切除肝细胞癌患者的放射学反应预测生存。

Aliment Pharmacol Ther. 2012 Jun;35(11):1343-50. doi: 10.1111/j.1365-2036.2012.05089.x. Epub 2012 Apr 8.

8

Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.经动脉化疗栓塞术治疗直径超过10厘米的巨大肝细胞癌：一项大型队列研究

Med Oncol. 2015 Mar;32(3):64. doi: 10.1007/s12032-015-0504-3. Epub 2015 Feb 15.

9

Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: A meta-analysis.肝细胞癌患者肝移植前经动脉化疗栓塞术：一项荟萃分析。

J Gastroenterol Hepatol. 2017 Jul;32(7):1286-1294. doi: 10.1111/jgh.13727.

10

Comment on: Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma.对《BCLC C期肝细胞癌的手术切除与经动脉化疗栓塞术对比》的评论

J Surg Oncol. 2015 Dec;112(8):907-8. doi: 10.1002/jso.24066.

引用本文的文献

1

Reduction in non-protein respiratory quotient is related to overall survival after hepatocellular carcinoma treatment.非蛋白呼吸商降低与肝癌治疗后的总生存期相关。

PLoS One. 2013;8(3):e55441. doi: 10.1371/journal.pone.0055441. Epub 2013 Mar 8.